EDP Sciences logo
Submit your paper
Search
Menu
All issues Volume 46 / No 1 (March 2014) J Extra Corpor Technol, 46 1 (2014) 84-90 References
Free Access
Issue
J Extra Corpor Technol
Volume 46, Number 1, March 2014
Page(s) 84 - 90
DOI https://doi.org/10.1051/ject/201446084
Published online 15 March 2014
  1. Oliver WC. Anticoagulation and coagulation management for ECMO. Semin Cardiothorac Vasc Anesth. 2009;13:154–175. [CrossRef] [PubMed] [Google Scholar]
  2. Urlesberger B, Zobel G, Zenz W, et al. Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. J Pediatr. 1996;129:264–268. [CrossRef] [Google Scholar]
  3. Bembea MM, Annich G, Rycus P, et al. Variability in anticoagulation management of patients on extracorporeal membrane oxygenation: An international survey. Pediatr Crit Care Med. 2013;14:e77–e84. [CrossRef] [PubMed] [Google Scholar]
  4. Olson ST, Bjork I, Sheffer R, et al. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin–proteinase reactions. J Biochem. 1992;267:12528–12538. [Google Scholar]
  5. Rosenberg RD. Biochemistry of heparin antithrombin interactions, and the physiologic role of this natural anticoagulant mechanism. Am J Med. 1989;87:2s–9s. [Google Scholar]
  6. Grossmann R, Babin-Ebell J, Misoph M, et al. Changes in coagulation and fibrinolytic parameters caused by extracorporeal circulation. Heart Vessels. 1996;11:310–317. [CrossRef] [PubMed] [Google Scholar]
  7. Koster A, Chew D, Kuebler W, et al. High antithrombin III levels attenuate hemostatic activation and leukocyte activation during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2003;126:906–907. [CrossRef] [Google Scholar]
  8. Despotis GJ, Joist JH, Hogue CW, et al. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation. J Thorac Cardiovasc Surg. 1995;100:46–54. [CrossRef] [Google Scholar]
  9. Avidan MS, Levy JH, van Aken H, et al. Recombinant human antithrombin III restores heparin responsiveness and decreases activation of coagulation in heparin-resistant patients during cardiopulmonary bypass. J Thorac Cardiovasc Surg. 2005;130:107–113. [CrossRef] [Google Scholar]
  10. Guzzetta NA, Miller BE, Todd K, et al. Clinical measures of heparin’s effect and thrombin inhibitor levels in pediatric patients with congenital heart disease. Anesth Analg. 2006;103:1131–1138. [CrossRef] [PubMed] [Google Scholar]
  11. Newall F, Ignjatovic V, Summerhayes R, et al. In vivo age dependency of unfractionated heparin in infants and children. Thromb Res. 2009;123:710–714. [CrossRef] [Google Scholar]
  12. Urlesberger B, Zobel G, Zenz W, et al. Activation of the clotting system during extracorporeal membrane oxygenation in term newborn infants. J Pediatr. 1996;129:264–268. [CrossRef] [Google Scholar]
  13. Niebler RA, Christensen M, Brenes R, et al. Antithrombin replacement during extracorporeal membrane oxygenation. Artif Organs. 2011;35:1024–1028. [CrossRef] [PubMed] [Google Scholar]
  14. Thrombate III prescribing information. GTC Biotherapeutics, Inc., 10 2012 Available at: www.thrombate.com. Accessed August 1, 2013. [Google Scholar]
  15. ATryn prescribing information. GTC Biotherapeutics, Inc., 11 2010 Available at: www.atryn.com. Accessed August 1, 2013. [Google Scholar]
  16. Tiede A, Campbell T, Shaffer DW, et al. Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situations. Thromb Haemost. 2008;99:616–622. [CrossRef] [PubMed] [Google Scholar]
  17. Konkle BA, Bauer KA, Weinstein R, et al. Use of recombinant human antithrombin in patients with congenital antithrombin deficiency undergoing surgical procedures. Hemostasis. 2003;43:390–394. [Google Scholar]
  18. Gruenwald CE, Manlhiot C, Crawford-Lean L, et al. Management and monitoring of anticoagulation for children undergoing cardiopulmonary bypass in cardiac surgery. J ECT. 2010;42:29–19. [Google Scholar]
  19. Stammers AH, Willett L, Fristoe L, et al. Coagulation monitoring during extracorporeal membrane oyxgenation: The role of thrombelastography. J ECT. 1995;27:137–145. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.